Growth Metrics

Erasca (ERAS) Leases (2020 - 2026)

Erasca posted quarterly Leases of $28.3 million for Q1 2026, down 10.34% year-on-year from $31.5 million in Q1 2025, and down 2.64% on a QoQ basis from $29.0 million in Q4 2025.

Erasca (ERAS) has 7 years of Leases data on file, last reported at $28.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Leases fell 10.34% year-over-year to $28.3 million; the trailing twelve-month figure through Mar 2026 stood at $28.3 million (down 10.34% YoY), and the FY2025 full-year result was $29.0 million, down 9.9% from the prior year.
  • Leases for Q1 2026 stood at $28.3 million, down from $29.0 million in the prior quarter.
  • Across five years, Leases topped out at $41.1 million in Q3 2022 and bottomed at $14.8 million in Q2 2022.
  • The 5-year median for Leases is $32.9 million (2024), against an average of $32.6 million.
  • The widest annual swing landed in 2022, when Leases soared 687.32%; it then declined 15.2% in 2025.
  • A 5-year view of Leases shows it stood at $40.4 million in 2022, then retreated by 6.33% to $37.9 million in 2023, then declined by 14.9% to $32.2 million in 2024, then decreased by 9.9% to $29.0 million in 2025, then slipped by 2.64% to $28.3 million in 2026.
  • The last three Leases figures came in at $28.3 million (Q1 2026), $29.0 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Erasca 4.21 Bn 3.97 Bn - 28.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.27 Mn
Dec 31, 2025 29.03 Mn
Sep 30, 2025 30.08 Mn
Jun 30, 2025 30.81 Mn
Mar 31, 2025 31.53 Mn
Dec 31, 2024 32.22 Mn
Sep 30, 2024 32.89 Mn
Jun 30, 2024 33.55 Mn
Mar 31, 2024 37.18 Mn
Dec 31, 2023 37.86 Mn
Sep 30, 2023 38.52 Mn
Jun 30, 2023 39.17 Mn
Mar 31, 2023 39.79 Mn
Dec 31, 2022 40.42 Mn
Sep 30, 2022 41.05 Mn
Jun 30, 2022 14.78 Mn
Mar 31, 2022 16.93 Mn
Dec 31, 2021 17.36 Mn
Sep 30, 2021 19.04 Mn
Jun 30, 2021 1.88 Mn
Dec 31, 2020 2.23 Mn